Nebenwirkungen · Lunsumio
Lunsumio 1 mg concentrate for solution for infusion Lunsumio 30 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 13
HOS-148561 · Präparat HOS-099926
Aspartate aminotransferase, increased Common Common 1 Upper respiratory tract infection includes upper respiratory tract infection, nasopharyngitis, sinusitis, respiratory tract infection, viral upper respiratory tract infection, rhinovirus infection, viral sinusitis, respiratory tract infection viral, and COVID-19 2 Viral infection includes cytomegalovirus infection, cytomegalovirus infection reactivation, Epstein-Barr virus infection reactivation, ophthalmic herpes simplex, and herpes zoster reactivation 3 Urinary tract infection (UTI) includes UTI, pyelonephritis acute, and Escherichia UTI 4 Pneumonia includes pneumonia and COVID-19 pneumonia 5 Lower respiratory tract infection includes lower respiratory tract infection and bronchitis 6 Sepsis includes sepsis and septic shock 7 Fungal infection includes Candida sepsis and Pneumocystis jirovecii pneumonia 8 Bacterial infection includes sinusitis bacterial and bacteraemia 9 Tumour flare includes tumour flare, pleural effusion, tumour inflammation and flank pain 10 Neutropenia includes neutropenia and neutrophil count decreased 11 Thrombocytopenia includes thrombocytopenia and platelet count decreased 12 By American Society for Transplantation and Cellular Therapy 13 Haemophagocytic lymphohistocytosis (HLH) includes HLH 14 Hypophosphatemia includes hypophosphatemia and blood phosphorus decreased 15 Hypokalemia includes hypokalemia and blood potassium decreased 16 Hypomagnesemia includes hypomagnesemia and blood magnesium decrease 17 Headache includes headache, migraine and head discomfort 18 Dizziness includes dizziness and vertigo 19 Consistent with the medical concept of ICANS according to American Society for Transplantation and Cellular Therapy and includes confusional state, ICANS, lethargy, encephalopathy, depressed level of consciousness, and memory impairment 20 The frequency calculation is based on additional clinical studies 21 Rash includes rash, rash erythematous, exfoliative rash, rash macular, rash maculo-papular, rash pruritic, rash pustular, erythema, palmar erythema, dermatitis, dermatitis acneiform, dermatitis contact, palmar-planta
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-07T15:05:00Z · SHA-256 a2ee59741e6f5b14dd4aa21cd069422f86ba73f8dcfa924635f33b255e1e3671 · Passage d109ab3e73ec412bd2ac013c0402db678215274cfbe9e1f4237de1b2ba513600 · Zeichen 5740–7980 im Abschnitt